30 Jul, 2021 10:16 AM
BARD1 Life Sciences Limited (ASX:BD1) (BARD1 or the Company) is pleased to announce that following the successful completion and issue of placement shares to sophisticated, institutional and profess...read more
30 Jul, 2021 10:03 AM
This notice is given by Immutep Limited ACN 009 237 889 (Company) under section 708A(5)(e) of the Corporations Act 2001 (Cth) (Corporations Act).
On 21 June 2021, the Company announced a non-unde...read more
27 Jul, 2021 02:51 PM
Chimeric Therapeutics Limited (“the Company”) (ASX: CHM), a clinical stage cell therapy company, is pleased to provide a summary of its activities for the quarter ended 30 June 2021.